Clinical Trials · NCT00001036
The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Enrollment
- 12
- Start date
- Not specified
- Locations
- 1 site, United States
- Primary endpoint
- Study in HIV Infections